Biofeedback Therapy Initial Evaluation Note

Encounter Information

Encounter type: Biofeedback Therapy — Initial Evaluation

Date/Time: [Date and time of encounter]

Setting: [in-person / telehealth—video / telehealth—audio only]

Duration: [Total minutes]

Clinician: [Name, credentials]

Referral source: [Referring clinician and organization]

Referral date: [Date]

Primary diagnosis or reason for referral: [Diagnosis or referral question as stated by referrer]

History source: [patient / collateral—specify relationship / medical records]

Interpreter used: [Yes—language and modality / No] (Include only if applicable.)

Referral & Chief Concern

[Reason for referral in referrer's terms, including clinical question to be answered—e.g., candidacy assessment, baseline physiologic pattern, protocol recommendation]

[Chief concern in patient's own words] (Include only if it adds value beyond referral.)

Patient-prioritized preliminary goals: [1-3 goals as stated by patient]

History of Present Illness

[Narrative summary beginning with chief concern and onset, clinical course, current severity, why presenting now, and key aggravating/relieving factors] (If patient cannot quantify symptoms, document best estimate with explanation and plan for diary tracking.)

• Pain details: [Location, quality, intensity 0-10, frequency, duration, triggers, relievers, associated symptoms, red flags] (Include only if relevant to referral.)
• Anxiety/stress details: [Triggers, panic features, avoidance, sleep impact, somatic symptoms] (Include only if relevant to referral.)
• Pelvic floor/bowel/bladder details: [Urgency, frequency, nocturia, leakage triggers, pad use, constipation pattern, incomplete emptying, straining, Bristol scale] (Include only if relevant to referral.)
• Respiratory details: [Dyspnea pattern, hyperventilation symptoms, exercise tolerance] (Include only if relevant to referral.)

Relevant History

• Pertinent past medical history: [Cardiopulmonary, neurologic, GI/GU, chronic pain conditions relevant to referral—positives and key negatives]
• Surgical history impacting target region: [Relevant procedures and dates]
• Psychiatric/behavioral health history: [Diagnoses, treatment history, current supports] (Include when treating stress, anxiety, or pain.)
• Allergies/sensitivities affecting sensors: [Adhesives / latex / gels / other—specify reactions]
• Implanted devices: [Pacemaker/ICD / stimulators / metal implants] (Note modality implications.)

Prior Treatments & Response

(Document conventional treatments to support medical necessity. Medicare requires documentation that prior treatments were tried before biofeedback.)

• [Treatment name], [Duration], [Response: none / partial / good—quantify if possible], [Reason stopped or continued], [Adherence and barriers]
• (If history incomplete, state what is missing and plan to obtain records.)

Current Medications Affecting Physiologic Signals

• [Medication name, dose, schedule] (Note effects on autonomic measures, muscle tone, tremor, or alertness.)
• Relevant substances: [Caffeine / nicotine / cannabis use pattern] (Include if relevant to baseline measures.)
• Concurrent therapies: [Services requiring coordination]

Functional Impact

(Tie 2-3 functional limitations directly to the condition and treatment goals.)

• ADLs/IADLs: [Limitations]
• Sleep: [Impact and quality]
• Work/school: [Impact]
• Exercise/activity: [Tolerance and participation]
• Quality of life: [Areas affected]

Baseline Outcome Measures

• [Instrument name], [Score], [Date], [Clinical interpretation]
• (Include only measures actually administered. If none completed, state "Not assessed" with explanation and plan.)

Objective Examination

• Vital signs: [Values with units and position] (Include if relevant to training targets.)
• Observation: [Posture, breathing pattern, movement patterns, affect/behavior relevant to session]
• Palpation at SEMG target sites: [Tenderness, tone, trigger points]
• Pelvic floor exam: [Consent obtained, chaperone name/role if present, clinically relevant findings] (Include only if within scope and consented; otherwise state "Not assessed" with reason.)

Candidacy & Precautions

• Candidacy indicators: [Ability to describe symptoms/goals], [Cognitive/communication capacity], [Motivation], [Realistic expectations]
• Contraindications/precautions screened: [Skin integrity], [Active infection/lesions], [Recent surgery], [Trauma considerations for sensor placement], [Conditions limiting signal interpretation]
• Stop criteria and escalation triggers: [Criteria and escalation plan]
• Safety screen status: [Completed / Not completed—reason and whether biofeedback deferred]

Biofeedback Assessment

(This section is required. If baseline physiologic assessment was deferred, explicitly state why and when it will be completed.)

Modality & Rationale

Modality: [SEMG / HRV / thermal / skin conductance / respiration / EEG-neurofeedback]

Target physiologic process: [Target process]

Rationale: [Link between modality, target, symptoms, and goals]

Setup

• Device: [Device/system name]
• Sensors: [Single-use / reusable], [Sensor type]
• Placement: [Sites with anatomic landmarks]
• Patient position: [Supine / sitting / standing / other]
• Signal quality: [Good / fair / poor], [Artifacts or limitations noted]

Recording Conditions

• Baseline duration: [Duration]
• Environmental conditions: [Quiet room, lighting, temperature]
• Instructions provided: [Spontaneous breathing / paced breathing at rate / relaxation cues]
• Provocations/tasks: [Simulated maneuver / cognitive stressor / movement / symptom trigger] (Note whether coaching was provided.)

Baseline Values

(Include only modalities used.)

• SEMG: [Resting level µV], [Peak contraction µV], [Endurance pattern], [Recruitment/relaxation timing], [Symmetry]
• HRV: [Baseline HR bpm], [Time-domain metrics—RMSSD, SDNN], [Paced breathing rate if used], [Coherence descriptors]
• Respiration: [Rate], [Pattern—thoracic/diaphragmatic/mixed], [Irregularities]
• Thermal: [Baseline finger temperature], [Change with relaxation]
• Skin conductance: [Baseline level µS], [Reactivity], [Recovery pattern]
• EEG/neurofeedback: [Sites], [Bandwidths], [Baseline amplitudes/ratios], [Artifact notes]

Interpretation

[Clinical interpretation tying physiologic findings to symptoms and modifiable targets] (Note uncertainty due to artifact, medication effects, or incomplete baseline.)

Patient Response

• Tolerance: [Tolerance of sensors and procedure]
• Learning response: [Ability to follow coaching and demonstrate self-regulation attempts]
• Immediate symptom change: [Changes reported by patient, if any]
• Safety events: [Adverse reactions, or "None observed/reported"]

Assessment

Working diagnosis: [Problem-focused impression with severity and chronicity]

Candidacy conclusion: [Appropriate / Appropriate with precautions / Not appropriate now—with explanation]

Medical necessity synthesis: [Diagnosis → Impairment → Functional limitation → Need for skilled biofeedback training]

Red flags or referral needs: [Differential diagnoses or findings requiring medical referral] (Include only if applicable.)

Goals

Patient-stated goals: [Verbatim or close paraphrase]

Clinician-formulated measurable goals:

• [Metric]: Reduce/improve from [baseline value] to [target value] within [timeframe], as measured by [method], under [conditions]
• (If baseline unknown, include initial measurement goal.)

Plan of Care

• Frequency/Duration: [Visits per week] for [total duration or number of visits]
• Interventions: [Biofeedback modality], [Education topics], [Complementary techniques—e.g., diaphragmatic breathing, relaxation training]
• Progression: [Plan for advancing task difficulty, positions, stressors, home practice complexity]
• Home program: [Specific practice], [Duration/frequency], [Tracking method]
• Outcome tracking: [Measures to repeat] at [intervals]
• Coordination: [Communication plan with referring provider]
• Next visit focus: [First treatment session content]

Consent Documentation

(Include only if sensitive anatomical sensor placement occurred or off-label device use applies; otherwise omit this section entirely.)

• Informed consent: [Obtained—risks discussed: skin irritation, discomfort, emotional distress; benefits; alternatives]
• Sensitive placement measures: [Draping], [Patient self-placement if used], [Chaperone name/role]
• Off-label device use: [Yes / No]; [Patient informed in writing and agreed]

Services Provided & Time

• [Evaluation components performed]
• [Baseline physiologic assessment]
• [Education/counseling provided]
• [Treatment provided this session, if any]
• Total encounter time: [Minutes]; Timed services: [Minutes] (if required by billing model)

Follow-Up & Coordination

Follow-up: [Next appointment date/timeframe], [Visit frequency]

Patient instructions: [Diary completion, home practice tasks, measurement tracking]

Provider coordination: [Plan to update referring provider], [Additional referrals with rationale]